{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:47:45Z","timestamp":1792097265272,"version":"4.4.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008795","name":"Manitoba Medical Services Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The mitochondrial pyruvate carrier (MPC), a central metabolic conduit linking glycolysis and mitochondrial metabolism, is instrumental in energy production. However, the role of the MPC in cancer is controversial. In particular, the importance of the MPC in glioblastoma (GBM) disease progression following standard temozolomide (TMZ) and radiation therapy (RT) remains unexplored.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Leveraging in vitro and in vivo patient-derived models of TMZ-RT treatment in GBM, we characterize the temporal dynamics of MPC abundance and downstream metabolic consequences using state-of-the-art molecular, metabolic, and functional assays.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our findings unveil a disease stage-specific role for the MPC, where in posttreatment GBM, but not therapy-na\u00efve tumors, the MPC acts as a central metabolic regulator that suppresses differentiation. Temporal profiling reveals a dynamic metabolic rewiring where a steady increase in MPC abundance favors a shift towards enhanced mitochondrial metabolic activity across patient GBM samples. Intriguingly, while overall mitochondrial metabolism is increased, acetyl-CoA production is reduced in posttreatment GBM cells, hindering histone acetylation and silencing neural differentiation genes in an MPC-dependent manner. Finally, the therapeutic translations of these findings are highlighted by the successful pre-clinical patient-derived orthotopic xenograft trials utilizing a blood-brain-barrier permeable MPC inhibitor, MSDC-0160, which augments standard TMZ-RT therapy to mitigate disease relapse and prolong animal survival.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our findings demonstrate the critical role of the MPC in mediating GBM aggressiveness and molecular evolution following standard TMZ-RT treatment, illuminating a therapeutically-relevant metabolic vulnerability to potentially improve survival outcomes for GBM patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/neuonc\/noaf008","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T17:16:42Z","timestamp":1736615802000},"page":"1193-1209","source":"Crossref","is-referenced-by-count":8,"title":["Disease stage-specific role of the mitochondrial pyruvate carrier suppresses differentiation in temozolomide and radiation-treated glioblastoma"],"prefix":"10.1093","volume":"27","author":[{"given":"Emma","family":"Martell","sequence":"first","affiliation":[{"name":"Department of Pathology, Rady Faculty of Health Sciences, Max Rady College of Medicine,\u00a0University of Manitoba , Winnipeg, Canada R3E 3P5"},{"name":"Department of Human Anatomy & Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Canada R3E 0J9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helgi","family":"Kuzmychova","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Canada R3E 3P5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshal","family":"Senthil","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Canada R3E 3P5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujala","family":"Chawla","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Canada R3E 3P5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Kaul","sequence":"additional","affiliation":[{"name":"Faculty of Science, University of Manitoba , Winnipeg, Manitoba, Canada R3T 2M8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akaljot","family":"Grewal","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Canada R3E 3P5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Versha","family":"Banerji","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba , Winnipeg, Manitoba, Canada R3A 1R9"},{"name":"Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba, Canada R3E 0J9"},{"name":"Paul Albrechtsen Research Institute CancerCare Manitoba , Winnipeg, Manitoba, Canada R3E 0V9"},{"name":"Department of Medical Oncology and Hematology, CancerCare Manitoba , Winnipeg, Manitoba, Canada R3E 0V9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Canada R3E 0T6"},{"name":"PrairieNeuro Research Center, Kleysen Institute for Advanced Medicine, Health Sciences Centre , Winnipeg, Manitoba, Canada R3E 0Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chitra","family":"Venugopal","sequence":"additional","affiliation":[{"name":"Department of Surgery, McMaster University , Hamilton, Ontario, Canada L8S 4K1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Canada R3E 0T6"},{"name":"PrairieNeuro Research Center, Kleysen Institute for Advanced Medicine, Health Sciences Centre , Winnipeg, Manitoba, Canada R3E 0Z3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamra E","family":"Werbowetski-Ogilvie","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba, Canada R3E 0J9"},{"name":"Texas Children\u2019s Hospital , Houston, TX, 77030 ,","place":["USA"]},{"name":"Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine , Houston, TX, 77030 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila K","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Surgery, McMaster University , Hamilton, Ontario, Canada L8S 4K1"},{"name":"Department of Biochemistry, McMaster University , Hamilton, Ontario, Canada L8S 4K1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3269-8100","authenticated-orcid":false,"given":"Tanveer","family":"Sharif","sequence":"additional","affiliation":[{"name":"Department of Pathology, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Canada R3E 3P5"},{"name":"Department of Human Anatomy & Cell Science, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Canada R3E 0J9"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"issue":"5","key":"2025062422074603700_CIT0001","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3322\/caac.21693","article-title":"Brain and other central nervous system tumor statistics, 2021","volume":"71","author":"Miller","year":"2021","journal-title":"CA Cancer J Clin."},{"issue":"5","key":"2025062422074603700_CIT0002","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"issue":"23","key":"2025062422074603700_CIT0003","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA."},{"issue":"10","key":"2025062422074603700_CIT0004","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med."},{"issue":"1","key":"2025062422074603700_CIT0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/neuonc\/nos273","article-title":"Standards of care for treatment of recurrent glioblastoma--are we there yet","volume":"15","author":"Weller","year":"2013","journal-title":"Neuro Oncol"},{"issue":"1","key":"2025062422074603700_CIT0006","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"issue":"6190","key":"2025062422074603700_CIT0007","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science."},{"issue":"1","key":"2025062422074603700_CIT0008","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"2025062422074603700_CIT0009","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41467-019-09853-z","article-title":"Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment","volume":"10","author":"Dirkse","year":"2019","journal-title":"Nat Commun."},{"issue":"4","key":"2025062422074603700_CIT0010","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular states, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell."},{"issue":"7785","key":"2025062422074603700_CIT0011","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41586-019-1775-1","article-title":"Longitudinal molecular trajectories of diffuse glioma in adults","volume":"576","author":"Barthel","year":"2019","journal-title":"Nature."},{"issue":"1","key":"2025062422074603700_CIT0012","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1038\/s41467-020-17186-5","article-title":"Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy","volume":"11","author":"Couturier","year":"2020","journal-title":"Nat Commun."},{"issue":"2","key":"2025062422074603700_CIT0013","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s43018-020-00159-4","article-title":"Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities","volume":"2","author":"Garofano","year":"2021","journal-title":"Nat Cancer"},{"issue":"12","key":"2025062422074603700_CIT0014","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s43018-022-00475-x","article-title":"A single-cell atlas of glioblastoma evolution under therapy reveals cell-intrinsic and cell-extrinsic therapeutic targets","volume":"3","author":"Wang","year":"2022","journal-title":"Nat Cancer"},{"issue":"3","key":"2025062422074603700_CIT0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"issue":"1","key":"2025062422074603700_CIT0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab."},{"issue":"5930","key":"2025062422074603700_CIT0017","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science."},{"issue":"6090","key":"2025062422074603700_CIT0018","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.1218099","article-title":"A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans","volume":"337","author":"Bricker","year":"2012","journal-title":"Science."},{"issue":"6090","key":"2025062422074603700_CIT0019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1218530","article-title":"Identification and functional expression of the mitochondrial pyruvate carrier","volume":"337","author":"Herzig","year":"2012","journal-title":"Science."},{"issue":"2","key":"2025062422074603700_CIT0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cmet.2019.11.002","article-title":"Regulation of tumor initiation by the mitochondrial pyruvate carrier","volume":"31","author":"Bensard","year":"2020","journal-title":"Cell Metab."},{"issue":"3","key":"2025062422074603700_CIT0021","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","article-title":"A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth","volume":"56","author":"Schell","year":"2014","journal-title":"Mol Cell."},{"issue":"1","key":"2025062422074603700_CIT0022","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s42255-018-0002-y","article-title":"Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer","volume":"1","author":"Bader","year":"2019","journal-title":"Nat Metab."},{"key":"2025062422074603700_CIT0023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mito.2013.08.006","article-title":"Metabolic features of the cell danger response","volume":"16","author":"Naviaux","year":"2014","journal-title":"Mitochondrion"},{"issue":"17","key":"2025062422074603700_CIT0024","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1158\/0008-5472.CAN-18-0267","article-title":"Cotargeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma","volume":"78","author":"Qazi","year":"2018","journal-title":"Cancer Res."},{"issue":"13","key":"2025062422074603700_CIT0025","doi-asserted-by":"crossref","first-page":"111420","DOI":"10.1016\/j.celrep.2022.111420","article-title":"Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma","volume":"40","author":"Qazi","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"2025062422074603700_CIT0026","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1038\/s41467-023-38049-9","article-title":"Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma","volume":"14","author":"Martell","year":"2023","journal-title":"Nat Commun."},{"issue":"1","key":"2025062422074603700_CIT0027","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40478-023-01604-y","article-title":"Compensatory cross-talk between autophagy and glycolysis regulates senescence and stemness in heterogeneous glioblastoma tumor subpopulations","volume":"11","author":"Martell","year":"2023","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"2025062422074603700_CIT0028","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00401-022-02506-4","article-title":"The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers","volume":"144","author":"Tatari","year":"2022","journal-title":"Acta Neuropathol."},{"issue":"3","key":"2025062422074603700_CIT0029","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/cancers15030670","article-title":"EGFR pathway expression persists in recurrent glioblastoma independent of amplification status","volume":"15","author":"Dhawan","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2025062422074603700_CIT0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat Genet."},{"issue":"43","key":"2025062422074603700_CIT0031","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"2025062422074603700_CIT0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-015-1951-6","article-title":"A novel stem cell culture model of recurrent glioblastoma","volume":"126","author":"Qazi","year":"2016","journal-title":"J Neurooncol."},{"issue":"3","key":"2025062422074603700_CIT0033","doi-asserted-by":"crossref","first-page":"100179","DOI":"10.1016\/j.xpro.2020.100179","article-title":"A patient-derived xenograft model of glioblastoma","volume":"1","author":"Chokshi","year":"2020","journal-title":"STAR Protoc"},{"issue":"2","key":"2025062422074603700_CIT0034","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2249.2008.03753.x","article-title":"Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment","volume":"154","author":"Pearson","year":"2008","journal-title":"Clin Exp Immunol."},{"issue":"21","key":"2025062422074603700_CIT0035","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1073\/pnas.1016627108","article-title":"Pyruvate carboxylase is required for glutamine-independent growth of tumor cells","volume":"108","author":"Cheng","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6","key":"2025062422074603700_CIT0036","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.cmet.2019.03.014","article-title":"Pyruvate-carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver","volume":"29","author":"Cappel","year":"2019","journal-title":"Cell Metab."},{"issue":"12","key":"2025062422074603700_CIT0037","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41576-020-0270-8","article-title":"The evolving metabolic landscape of chromatin biology and epigenetics","volume":"21","author":"Dai","year":"2020","journal-title":"Nat Rev Genet."},{"issue":"5","key":"2025062422074603700_CIT0038","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1101\/gad.12.5.599","article-title":"Histone acetylation and transcriptional regulatory mechanisms","volume":"12","author":"Struhl","year":"1998","journal-title":"Genes Dev."},{"issue":"50","key":"2025062422074603700_CIT0039","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"2025062422074603700_CIT0040","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41556-023-01274-x","article-title":"Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment","volume":"25","author":"Giafaglione","year":"2023","journal-title":"Nat Cell Biol."},{"issue":"6","key":"2025062422074603700_CIT0041","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2174\/1567205011666140616113406","article-title":"An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer\u2019s disease","volume":"11","author":"Shah","year":"2014","journal-title":"Curr Alzheimer Res."},{"issue":"368","key":"2025062422074603700_CIT0042","doi-asserted-by":"crossref","first-page":"368ra174","DOI":"10.1126\/scitranslmed.aag2210","article-title":"Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson\u2019s disease","volume":"8","author":"Ghosh","year":"2016","journal-title":"Sci Transl Med."},{"issue":"1","key":"2025062422074603700_CIT0043","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1038\/s41598-018-25588-1","article-title":"Alterations in cell motility, proliferation, and metabolism in novel models of acquired temozolomide resistant glioblastoma","volume":"8","author":"Tiek","year":"2018","journal-title":"Sci Rep."},{"issue":"51","key":"2025062422074603700_CIT0044","doi-asserted-by":"crossref","first-page":"E8247","DOI":"10.1073\/pnas.1610921114","article-title":"An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma","volume":"113","author":"Gujar","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"2025062422074603700_CIT0045","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1158\/1541-7786.MCR-13-0576","article-title":"Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors","volume":"12","author":"Panosyan","year":"2014","journal-title":"Mol Cancer Res."},{"issue":"1","key":"2025062422074603700_CIT0046","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1038\/s41467-021-24108-6","article-title":"Suppression of mitochondrial ROS by prohibitin drives glioblastoma progression and therapeutic resistance","volume":"12","author":"Huang","year":"2021","journal-title":"Nat Commun."},{"issue":"22","key":"2025062422074603700_CIT0047","doi-asserted-by":"crossref","first-page":"35639","DOI":"10.18632\/oncotarget.16767","article-title":"Metabolic targeting of EGFRvIII\/PDK1 axis in temozolomide resistant glioblastoma","volume":"8","author":"Velpula","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"2025062422074603700_CIT0048","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1038\/s41467-020-17512-x","article-title":"Purine metabolism regulates DNA repair and therapy resistance in glioblastoma","volume":"11","author":"Zhou","year":"2020","journal-title":"Nat Commun."},{"issue":"1","key":"2025062422074603700_CIT0049","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"2025062422074603700_CIT0050","first-page":"D991","article-title":"NCBI GEO: archive for functional genomics data sets--update","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noaf008\/61414970\/noaf008.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/5\/1193\/61414970\/noaf008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/5\/1193\/61414970\/noaf008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:07:57Z","timestamp":1750817277000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/27\/5\/1193\/7951875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,1,11]]},"published-print":{"date-parts":[[2025,6,21]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noaf008","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,1,11]]}}}